The Next New Normal

Using the Biosymtec Monitor, Nurse Kimberly Johnson can view the graph of her vital data on her smartphone and forward the graph to her physician.   Kimberly has asthma and her doctor wants to monitor her closely, especially since she is a healthcare worker.   Note on March 18 she did have a minor respiratory infection.

Actual patient graph from Research Study.

      Go back to previous view.

The final Design Phase of the Biosymtec Monitor is also ready to begin, and if funding is achieved soon, devices could be available in 35 weeks for clinical trials during the Winter 2020-2021 influenza/COVID-19 season.   Licensing or private-label manufacturing is available.   Contact Thomas W. French, President, Biosymtec Medical, Inc.